Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive Ganciclovir or Aciclovir in ICU Patients
NCT02152358Phase 4Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Feb 2014
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of ganciclovir, aciclovir in cytomegalovirus infection (CMV), herpes simplex virus infection, sponsored by Assistance Publique-Hôpitaux de Marseille. Started Feb 2014; status: completed.
02
Drugs
gancicloviraciclovir
03
Conditions
cytomegalovirus infection (CMV)herpes simplex virus infection
Beyond the preview
Go deeper on NCT02152358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02152358.